Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


Revenue 2017


The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Shire's 2013 CNS, immunology and metabolic's sales performance.


Novartis pulls EU filing for $3.4bn eye therapy Xiidra

Novartis pulls EU filing for $3.4bn eye therapy Xiidra

Novartis licensed rights to the drug from Takeda shortly after the Japanese drugmaker finalised its $62bn takeover of Shire, paying $3.4bn upfront with another $1.9bn tied to milestones – including ... The Xiidra deal was hailed by Takeda as a great

In-House Team of the Year

Takeda established a dedicated External Affairs Directorate in 2019 to handle the complex challenges arising from the increased size and complexity of the company following the acquisition of Shire. ... The legacy Shire organisation had a small external


With the integration of Shire into our UK &Ireland team we will continue to empower our people to be ambitious and change the game for patients, a key achievement of our

Pharma funding and M&A in 2020

Pharma funding and M&A in 2020 All this in the same year that Japan’s Takeda acquired Shire, making the combined entity one of the top ten pharmaceutical firms by revenue (and only the second non- American

After FDA refusal, Takeda builds case for subcutaneous Entyvio

After FDA refusal, Takeda builds case for subcutaneous Entyvio Patent expiries and a weak near-term pipeline were the main drivers for Takeda's  $63bn takeover of Shire, which completed in January 2019.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia